Neuland Labs. (NEULANDLAB)

STALWART

FairStock Score: 33/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹14,977
Market Cap₹16,454.33 Cr
P/E Ratio91.86
ROCE18.66%
ROE11.75%
Dividend Yield0.09%
Profit Growth-40.26%
Debt/Equity0.16
Sales Growth2.71%
Free Cash Flow₹1,900 Cr
Promoter Holding32.63%
52-Week Range₹11,500 — ₹19,747
SectorPharmaceuticals & Biotechnology
Book Value₹1,188.48

Neuland Labs. trades with a P/E ratio of 91.86, ROCE of 18.66%, ROE of 11.75%, profit growth of -40.26%, debt-to-equity of 0.16. The FairStock Score of 33/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer